257 related articles for article (PubMed ID: 22758630)
1. Omics approaches in cystic fibrosis research: a focus on oxylipin profiling in airway secretions.
Eiserich JP; Yang J; Morrissey BM; Hammock BD; Cross CE
Ann N Y Acad Sci; 2012 Jul; 1259(1):1-9. PubMed ID: 22758630
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic profiling of regulatory lipid mediators in sputum from adult cystic fibrosis patients.
Yang J; Eiserich JP; Cross CE; Morrissey BM; Hammock BD
Free Radic Biol Med; 2012 Jul; 53(1):160-71. PubMed ID: 22580336
[TBL] [Abstract][Full Text] [Related]
3. Oxidative stress and abnormal bioactive lipids in early cystic fibrosis lung disease.
Scholte BJ; Horati H; Veltman M; Vreeken RJ; Garratt LW; Tiddens HAWM; Janssens HM; Stick SM;
J Cyst Fibros; 2019 Nov; 18(6):781-789. PubMed ID: 31031161
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomics reveals an altered cystic fibrosis in vitro bronchial epithelial secretome.
Peters-Hall JR; Brown KJ; Pillai DK; Tomney A; Garvin LM; Wu X; Rose MC
Am J Respir Cell Mol Biol; 2015 Jul; 53(1):22-32. PubMed ID: 25692303
[TBL] [Abstract][Full Text] [Related]
5. Think big - think omics.
Wevers RA; Blau N
J Inherit Metab Dis; 2018 May; 41(3):281-283. PubMed ID: 29541953
[No Abstract] [Full Text] [Related]
6. Inflammation in cystic fibrosis: An update.
Roesch EA; Nichols DP; Chmiel JF
Pediatr Pulmonol; 2018 Nov; 53(S3):S30-S50. PubMed ID: 29999593
[TBL] [Abstract][Full Text] [Related]
7. The metabolic footprint of the airway bacterial community in cystic fibrosis.
Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
[TBL] [Abstract][Full Text] [Related]
8. Metabolomic profiling reveals biochemical pathways and biomarkers associated with pathogenesis in cystic fibrosis cells.
Wetmore DR; Joseloff E; Pilewski J; Lee DP; Lawton KA; Mitchell MW; Milburn MV; Ryals JA; Guo L
J Biol Chem; 2010 Oct; 285(40):30516-22. PubMed ID: 20675369
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis.
Esther CR; Coakley RD; Henderson AG; Zhou YH; Wright FA; Boucher RC
Chest; 2015 Aug; 148(2):507-515. PubMed ID: 25611918
[TBL] [Abstract][Full Text] [Related]
10. Relationships between the lipid content and the rheological properties of airway secretions in cystic fibrosis.
Galabert C; Jacquot J; Zahm JM; Puchelle E
Clin Chim Acta; 1987 Apr; 164(2):139-49. PubMed ID: 3594907
[TBL] [Abstract][Full Text] [Related]
11. Physical and functional properties of airway secretions in cystic fibrosis--therapeutic approaches.
Puchelle E; de Bentzmann S; Zahm JM
Respiration; 1995; 62 Suppl 1():2-12. PubMed ID: 7792436
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloprotease-9 dysregulation in lower airway secretions of cystic fibrosis patients.
Gaggar A; Li Y; Weathington N; Winkler M; Kong M; Jackson P; Blalock JE; Clancy JP
Am J Physiol Lung Cell Mol Physiol; 2007 Jul; 293(1):L96-L104. PubMed ID: 17384080
[TBL] [Abstract][Full Text] [Related]
13. Terminal glycosylation in cystic fibrosis (CF): a review emphasizing the airway epithelial cell.
Rhim AD; Stoykova L; Glick MC; Scanlin TF
Glycoconj J; 2001 Sep; 18(9):649-59. PubMed ID: 12386452
[TBL] [Abstract][Full Text] [Related]
14. Distinctive metabolic profiles between Cystic Fibrosis mutational subclasses and lung function.
Masood A; Jacob M; Gu X; Abdel Jabar M; Benabdelkamel H; Nizami I; Li L; Dasouki M; Abdel Rahman AM
Metabolomics; 2021 Jan; 17(1):4. PubMed ID: 33394183
[TBL] [Abstract][Full Text] [Related]
15. Cystic Fibrosis Rapid Response: Translating Multi-omics Data into Clinically Relevant Information.
Cobián Güemes AG; Lim YW; Quinn RA; Conrad DJ; Benler S; Maughan H; Edwards R; Brettin T; Cantú VA; Cuevas D; Hamidi R; Dorrestein P; Rohwer F
mBio; 2019 Apr; 10(2):. PubMed ID: 30992350
[TBL] [Abstract][Full Text] [Related]
16. Airway Mucosal Host Defense Is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity.
Polineni D; Dang H; Gallins PJ; Jones LC; Pace RG; Stonebraker JR; Commander LA; Krenicky JE; Zhou YH; Corvol H; Cutting GR; Drumm ML; Strug LJ; Boyle MP; Durie PR; Chmiel JF; Zou F; Wright FA; O'Neal WK; Knowles MR
Am J Respir Crit Care Med; 2018 Jan; 197(1):79-93. PubMed ID: 28853905
[TBL] [Abstract][Full Text] [Related]
17. Profiling the Oxylipin and Endocannabinoid Metabolome by UPLC-ESI-MS/MS in Human Plasma to Monitor Postprandial Inflammation.
Gouveia-Figueira S; Späth J; Zivkovic AM; Nording ML
PLoS One; 2015; 10(7):e0132042. PubMed ID: 26186333
[TBL] [Abstract][Full Text] [Related]
18. Effect of polarized release of CXC-chemokines from wild-type and cystic fibrosis murine airway epithelial cells.
Farberman MM; Ibricevic A; Joseph TD; Akers KT; Garcia-Medina R; Crosby S; Clarke LL; Brody SL; Ferkol TW
Am J Respir Cell Mol Biol; 2011 Aug; 45(2):221-8. PubMed ID: 20639462
[TBL] [Abstract][Full Text] [Related]
19. Gene therapy for cystic fibrosis using E1-deleted adenovirus: a phase I trial in the nasal cavity. The University of North Carolina at Chapel Hill.
Boucher RC; Knowles MR; Johnson LG; Olsen JC; Pickles R; Wilson JM; Engelhardt J; Yang Y; Grossman M
Hum Gene Ther; 1994 May; 5(5):615-39. PubMed ID: 7519885
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms and markers of airway inflammation in cystic fibrosis.
De Rose V
Eur Respir J; 2002 Feb; 19(2):333-40. PubMed ID: 11866015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
